Varicella
📧 Sign up to get email alerts when something new happens for Varicella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058) [Phase 3]
Phase 3 clinical trial evaluating immunogenicity and safety of VARIVAX in healthy Russian participants has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine [Phase 4]
Phase 4 trial update evaluating safety and immunogenicity of measles, varicella, and hepatitis A vaccines.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [Phase 3]
Phase 3 study comparing frozen versus refrigerated MMRV vaccine (V221-016) completed.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox [Phase 3]
Phase 3 trial evaluating a varicella vaccine and a combined Measles, Mumps, Rubella, and Varicella vaccine by GlaxoSmithKline has completed,…
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03) [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of the VARIVAX PE34 process in children with varicella; results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age [Phase 3]
Phase 3 trial updating immunogenicity and safety of NBP608 compared to Varivax in healthy children aged 12 months to 12 years with varicella…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients [Phase 3]
A Phase 3 trial update from GlaxoSmithKline reports results on detecting and characterising Varicella Zoster Virus from dermal lesions in pa…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056) [Phase 3]
A Phase 3 study evaluating the safety, tolerability, and immunogenicity of the VARIVAX varicella vaccine in healthy Indian children.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: ProQuad® Intramuscular vs Subcutaneous [Phase 3]
Phase 3 trial comparing ProQuad intramuscular vs subcutaneous administration in measles/mumps rubella/varicella indications; results posted …
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine [Phase 3]
A Phase 3 lot-consistency trial of a live attenuated varicella vaccine developed by Sinovac has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) [Phase 3]
Phase 3 immunogenicity and safety study assessing concomitant administration of ProQuad and Infanrix Hexa has been completed and results pos…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) [Phase 3]
A Phase 3 comparative study evaluating immunogenicity and safety of a two-dose Regimen of ProQuad manufactured with rHA (V221-038) for measl…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV [Phase 3]
Phase 3 trial update for JE-CV in children previously immunized with JE-CV; study completed and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines [Phase 3]
A blind, randomized, controlled Phase 3 trial of a live attenuated varicella vaccine developed by Sinovac Dalian Vaccine Technology Co., Ltd…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children [Phase 1]
Phase 1 safety study of live attenuated varicella vaccines in healthy adults, adolescents, and children has been completed.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Safety Study of ProQuad® rHA in Infants (V221-037) [Phase 3]
Phase 3 safety study of ProQuad rHA in infants completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. [Phase 3]
Phase 3 clinical trial evaluating two-dose regimens of GlaxoSmithKline varicella vaccines in healthy children aged 12-23 months; completed w…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds [Phase 2]
Phase 2 immunogenicity and safety study of GSK's 208136 vaccine formulated with new seed strains for measles and rubella; results posted aft…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM [Phase 3]
Phase 3 trial comparing GSK's MMRV vaccine to Priorix; the study is completed and results were posted on 2017-09-25.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: Tzanck Smear With Methylene Blue Stain for Herpes [Phase 3]
A Phase 3 clinical trial evaluating Tzanck smear with methylene blue stain for herpes diagnosis is currently in unknown status.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Varicella-related Hospitalizations in Turkey
A completed clinical trial sponsored by Eskisehir Osmangazi University in Turkey studied varicella (chickenpox) hospitalizations. The trial …
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine
An update on cytokine production and immune responses to Varicella Zoster Virus in elderly recipients of the zoster vaccine; the trial statu…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). [Phase 2]
A Phase 2 trial update on the immunogenicity and safety of GlaxoSmithKline's live attenuated varicella vaccine VARILRIX, with completed stat…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Study of Two Formulations of GSK Biologicals' Varicella Vaccine [Phase 2]
A Phase 2 trial comparing two formulations of GlaxoSmithKline's varicella vaccine has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults [Phase 1]
A phase 1 dose-escalation study evaluated the safety and potential efficacy of MG1111 in healthy adults; the trial has completed.